- Funding & Notices
- News & Media
- About Translation
- About NCATS
Rare Disease Day at NIH, held this year on Feb. 28, exemplifies NCATS’ approach to rare diseases research: involving patients as partners throughout the translational research process to ensure that research and interventions address patients’ needs.April E-Newsletter Now Available
On May 8-11, 2019, NCATS will jointly host an international rare diseases research event that will bring together leading scientific experts, patients and advocates to discuss topics, such as gene therapy, gene and cell editing, and more.
Scientists at Brigham and Women’s Hospital collaborated with NCATS high-throughput screening experts to develop a different approach against inflammation, identifying four compounds that can potentially turn on anti-inflammatory activity.
The NCATS-Eli Lilly externship opportunity for CTSA Program-supported trainees, scholars and investigators is closing soon. Submit application materials via email to email@example.com by April 16 for consideration.
Clinical and Translational Science Awards Program
Apply Now for the ASPIRE Design Challenges
The NCATS ASPIRE Design Challenges are designed to advance innovative and catalytic approaches towards solving the opioid crisis by developing “A Specialized Platform for Innovative Research Exploration” (ASPIRE) to aid in the discovery and development of novel and effective treatments, while at the same time making the process faster and more cost-effective. The NCATS ASPIRE Design Challenges are part of the of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. Learn more about the ASPIRE Design Challenges.